{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-000271","form_type":"8-K","ticker":null,"cik":"0000764195","company_name":"VBI Vaccines Inc/BC","filed_at":"2025-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.304922+00:00","generated_at":"2026-05-28T16:32:55.751916+00:00","sec_items":["2.01","3.03","5.01","5.02","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"VBI Vaccines completes sale to K2 HealthVentures affiliate; common shares cancelled for no value, company to deregister","bullets":["All outstanding common shares redeemed and cancelled without consideration; existing shareholders receive zero.","Company and subsidiaries become wholly owned by K2 VBI Equity Trust (K2 HealthVentures affiliate) and exit CCAA protection.","All directors and executive officers resigned; replaced by nominees of K2.","Company plans to cease reporting issuer status in Canada and deregister shares under SEC.","Transaction closed January 3, 2025, per court-approved acquisition agreement dated Oct 24, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-000271","json":"https://secwatch.observer/filing/0001493152-25-000271.json","markdown":"https://secwatch.observer/filing/0001493152-25-000271.md","text":"https://secwatch.observer/filing/0001493152-25-000271.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/764195/000149315225000271/0001493152-25-000271-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/764195/000149315225000271/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T16:32:55.751916+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b0a9f098052a30013dc54b7a7bf6a09499a397ae","claim":"VBI Vaccines Inc/BC underwent a change of control involving K2 VBI Equity Trust, LLC for all previously issued and outstanding common shares of the Company have been redeemed and cancelled without consideration; new shares issued to Purchaser in con (closed 2025-01-03).","evidence_excerpt":"On January 3, 2025, the Company completed the transactions (collectively, the","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/764195/000149315225000271/0001493152-25-000271-index.htm","confidence":0.95,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Counterparty","value":"K2 VBI Equity Trust, LLC"},{"label":"Consideration","value":"all previously issued and outstanding common shares of the Company have been redeemed and cancelled without consideration; new shares issued to Purchaser in con"},{"label":"Closing","value":"2025-01-03"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}